CIK 0001005286 · Accelerated filer<br>Smaller reporting company
LIFECORE BIOMEDICAL, INC. \DE\
Sign in to watch- Ticker
- LFCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- May 25
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943025618
- Phone
- 9523684300
- Business address
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Former names
- LANDEC CORP \CA\
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Schechter Joshua Director | Grant or award · Restricted Stock Unit | +9,554 | 9,554 | ||
| 2023-02-01 | Diradoorian Raymond H Director | Grant or award · Restricted Stock Unit | +9,554 | 9,554 | ||
| 2023-02-01 | Barbarosh Craig A. Director | Grant or award · Restricted Stock Unit | +9,554 | 9,554 | ||
| 2023-02-01 | Kiper Christopher S Director | Grant or award | +3,981 | 9,887 | ||
| 2023-01-20 | Diradoorian Raymond H Director | Grant or award | +2,768 | $7.00 | $19K | 2,768 |
| 2023-01-20 | Diradoorian Raymond H Director | Option exercise · Restricted Stock Unit | −2,768 | $7.00 | $19K | 0 |
| 2023-01-09 | Calloway Nathaniel Director | Grant or award · Restricted Stock Unit | +5,906 | 5,906 | ||
| 2023-01-09 | Kiper Christopher S Director | Grant or award | +5,906 | 5,906 | ||
| 2023-01-09 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner | Purchase · Series A Convertible Preferred Stock | +1,560 | $1,000.00 | $1.6M | 1,560 |
| 2023-01-09 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner | Purchase · Series A Convertible Preferred Stock | +1,040 | $1,000.00 | $1.0M | 1,040 |
| 2023-01-09 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner | Purchase · Series A Convertible Preferred Stock | +650 | $1,000.00 | $650K | 650 |
| 2022-11-25 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner | Purchase | +345,260 | $7.97 | $2.8M | 1,972,853 |
| 2022-11-25 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner | Purchase | +282,486 | $7.97 | $2.3M | 2,438,180 |
| 2022-10-24 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner | Purchase | +103,000 | $8.09 | $833K | 1,627,593 |
| 2022-10-24 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner | Purchase | +147,000 | $8.09 | $1.2M | 2,155,694 |
| 2022-08-11 | Hall James G Chief Executive Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +150,000 | $11.31 | $1.7M | 150,000 |
| 2022-08-11 | Hall James G Chief Executive Officer | Grant or award · Right to Buy Restricted Stock Unit (RSU) | +45,000 | $11.31 | $509K | 45,000 |
| 2022-08-11 | Morberg John D Chief Financial Officer | Grant or award · Incentive Stock Option (Right to Buy) | +409 | $11.31 | $5K | 409 |
| 2022-08-11 | Morberg John D Chief Financial Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +12,591 | $11.31 | $142K | 13,000 |
| 2022-08-11 | Morberg John D Chief Financial Officer | Grant or award · Restricted Stock Unit | +13,500 | $11.31 | $153K | 13,500 |
Page 7 of 8 · 160 trades